Product Images Silodosin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Silodosin NDC 62332-406 by Alembic Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
30 Capsues in 1 Bottle - silodosin 4mg
This is a description of a prescription drug called Silodosin, which comes in a capsule form with 4mg of dosage. Each capsule is to be orally taken once daily with a meal. It is manufactured by Alembic Pharmaceuticals Limited in Gujarat, India, and distributed by Alembic Pharmaceuticals, Inc. in the USA. The capsules should be stored at 25°C (77°F), and protected from light and moisture. The package insert provides prescribing information, and it has a GTIN code of 00362332405305.*
30 Capsules - silodosin 8mg
Figure 1 - silodosin figur1
Figure 2 - silodosin figur2
The text describes a study analyzing the change from baseline (pre-treatment) in IPSS total score. The results indicate statistical significance (p<0.0001) and involve variables such as Aries Placebo and Silodosin Capsules 8 mg. However, without more context, it is unclear what the IPSS total score represents or the purpose of the study.*
Figure 3 - silodosin figur3
The text is reporting data on the change from baseline in IPSS total score for a clinical trial with a placebo group and a group that received Silodosin Capsules 8 mg. The notation ** p<0.0001 suggests that there was a statistically significant difference between the two groups. The data is shown graphically in a table indicating the score for each group at Day 28 and Day 84/LOCF.*
Figure 4 - silodosin figur4
The text represents a table showing changes in maximum flow rate (Qmax) for a medication called Silodosin Capsules 8 mg compared to a placebo. The asterisk denotes a statistically significant difference (p<0.05) from the placebo group. The values in the table represent the change from baseline Qmax in mL/sec. The last row shows the day of measurement.*
Figure 5 - silodosin figur5
The text describes a graph or chart displaying changes from a baseline in Qmax (maximum urine flow rate in mL per second) over time (in days). The data includes two sets of values, one for a placebo group and one for a group taking Silodosin Capsules 8 mg. The asterisk and "p<0.05" indicate a statistically significant difference between the two groups at some point in time (not specified). The legend provides information about the time intervals measured (-1 to 84 days) and the method of analysis used (last observation carried forward, or LOCF).*
Structure - silodosin structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.